Post-treatment T1 shortening in primary CNS lymphoma

Journal of Neuro-Oncology

Volumn 111, Issue 1, 2013, Pages 25-31

  Karimi, Sasan ^a   Hatzoglou, Vaios ^a   Punia, Vineet ^a   Partovi, Sasan ^a   Abrey, Lauren E ^a   Deangelis, Lisa M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Methotrexate; PCNSL; Post treatment T1 hyperintensity

Indexed keywords

METHOTREXATE; PROCARBAZINE; RITUXIMAB; STEROID; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84871804827     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0984-3     Document Type: Article

References (28)

1. Olson JE, Janney CA, Rao RD et al (2002) The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 95:1504-1510
2. Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K (2009) Primary CNS lymphoma in immunocompetent patients. Oncologist 14:526-539
3. Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel FS, Burger PC (1988) Increasing incidence of primary brain lymphoma in the US. Cancer 62:2461-2465
4. Jack CR Jr, Reese DF, Scheithauer BW (1986) Radiographic findings in 32 cases of primary CNS lymphoma. AJR Am J Roentgenol 146:271-276
5. Kuker W, Nagele T, Thiel E, Weller M, Herlinger U (2005) Primary central nervous system lymphomas (PCNSL): MRI response criteria revised. Neurology 65:1129-1131
6. Haldorsen IS, Espeland A, Larsson EM (2011) Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 32:984-992
7. DeAngelis LM (1990) Primary central nervous system lymphoma imitates multiple sclerosis. J Neurooncol 1990(9):177-181
8. Ayuso-Peralta L, Orti-Pareja M, Zurdo-Hernandez M et al (2001) Cerebral lymphoma presenting as a leukoencephalopathy. J Neurol Neurosurg Psychiatry 71:243-246
9. DeAngelis LM (1993) Cerebral lymphoma presenting as a nonenhancing lesion on computed tomographic/magnetic resonance scan. Ann Neurol 33:308-311
10. Johnson BA, Fram EK, Johnson PC, Jacobowitz R (1997) The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features. AJNR Am J Neuroradiol 18:563-572
11. Lai R, Rosenblum MK, DeAngelis LM (2002) Primary CNS lymphoma: a whole-brain disease? Neurology 59:1557-1562
12. Glass J, Gruber ML, Cher L, Hochberg FH (1994) Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 81:188-195
13. Abrey LE, DeAngelis LM, Yahalom J (1998) Long-term survival in primary CNS lymphoma. J Clin Oncol 16:859-863
14. Ferreri AJ, Reni M, Villa E (2000) Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials. Ann Oncol 11:927-937
15. Fliessbach K, Urbach H, Helmstaedter C et al (2003) Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma. Arch Neurol 60:563-568
16. Neuwelt EA, Guastadisegni PE, Varallyay P, Doolittle ND (2005) Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery. AJNR Am J Neuroradiol 26:258-265
17. Cakirer S, Karaarsian E, Arslan A (2003) Spontaneously T1-hyperintense lesions of the brain on MRI: a pictorial review. Curr Probl Diagn Radiol 32:194-217
18. Bonneville F, Cattin F, Marsot-Dupuch K, Dormant D, Bonneville JF, Chiras J (2006) T1 signal hyperintensity in the sellar region: spectrum of findings. Radiographics 26:93-113
19. Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M (2002) Hemorrhage and VEGF expression in a case of primary CNS lymphoma. J Neurooncol 58:53-56
20. Kim IY, Jung S, Jung TY, Kang SS, Choi C (2008) Primary central nervous system lymphoma presenting as an acute massive intracerebral hemorrhage: case report with immunohistochemical study. Surg Neurol 70:308-311
21. Kimura N, Ishibashi M, Masuda T et al (2009) Primary central nervous system lymphoma with cortical laminar hemorrhage. J Neurol Sci 15(287):281-284
22. Rogers LR (2003) Cerebrovascular complications in cancer patients. Neurol Clin 21:167-192
23. Wall RT, Harlan JM, Harker LA, Striker GE (1980) Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 18:113-121
24. Ling Q, Hajjar KA (2000) Inhibition of endothelial cell thromboresistance by homocysteine. J Nutr 130(suppl.):373-376
25. Haimes AB, Zimmerman RD, Morgello S et al (1989) MR imaging of brain abscesses. AJR Am J Roentgenol 152:1073-1085
26. Baba A, Yamagami S, Mizuo H, Iwata H (1980) Microassay of cysteine sulfinic acid by an enzymatic cycling method. Anal Biochem 101:288-293
27. Pullan LM, Olney JW, Price MT et al (1987) Excitatory amino acid receptor potency and subclass specificity of sulfur-containing amino acids. J Neurochem 49:1301-1307
28. Curras MC, Dingledine R (1992) Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4- isoxazolepropionate receptors. Mol Pharmacol 41:520-526